Expression of Concern: Fezolinetant and Elinzanetant Therapy for Menopausal Women Experiencing Vasomotor Symptoms: A Systematic Review and Meta-Analysis
- PMID: 41538797
- DOI: 10.1097/AOG.0000000000006180
Expression of Concern: Fezolinetant and Elinzanetant Therapy for Menopausal Women Experiencing Vasomotor Symptoms: A Systematic Review and Meta-Analysis
Expression of concern for
-
Fezolinetant and Elinzanetant Therapy for Menopausal Women Experiencing Vasomotor Symptoms: A Systematic Review and Meta-analysis.Obstet Gynecol. 2025 Mar 1;145(3):253-261. doi: 10.1097/AOG.0000000000005812. Epub 2025 Jan 2. Obstet Gynecol. 2025. PMID: 39746208
References
REFERENCE
-
- Menegaz de Almeida A, Oliveira P, Lopes L, Leite M, Morbach V, Alves Kelly F, et al. Fezolinetant and elinzanetant therapy for menopausal women experiencing vasomotor symptoms: a systematic review and meta-analysis. Obstet Gynecol 2025;145:253–61. doi: 10.1097/AOG.0000000000005812 - DOI
Publication types
LinkOut - more resources
Full Text Sources
